What PainTEQ does

PainTEQ is a privately held medical device company headquartered in Tampa, Florida, that develops and commercializes minimally invasive solutions for sacroiliac (SI) joint dysfunction. Founded in 2014, the company targets interventional pain management specialists, spine surgeons, and orthopedic surgeons performing procedures in physician offices, outpatient surgical centers, and hospitals. PainTEQ's flagship product, the LinQ SI Joint Stabilization System, uses a single bone allograft implant placed via a posterior approach through a small incision and employs a patented drill-less fusion technique. The portfolio was expanded in May 2026 with TRAQ, a next-generation posterior implant engineered for bi-cortical fixation through the same tissue-sparing approach, alongside single-use surgical instruments and the OfficeLinQ in-office procedure variant.

The company operates a sales-led, direct distribution model targeting U.S.-based healthcare providers. Revenue is generated from hardware sales of implants and single-use disposable instrument kits used per procedure, with procedure-based pricing determined through physician consultation and insurance authorization; Medicare Local Coverage Determination requires two diagnostic injections with ≥75% pain relief prior to coverage. PainTEQ supports adoption through physician training and certification programs, a peer-reviewed clinical evidence base (14 published studies including a 258-patient retrospective study and the prospective SECURE and TRAQTION studies), and a sales motion anchored in clinical evidence and physician education. As of October 2025, the LinQ system had been used in over 14,000 procedures.

PainTEQ completed a $35 million financing in July 2023 led by MVolution Partners, followed by a majority growth recapitalization in August 2025 co-led by Signet Healthcare Partners and Windham Capital Partners to accelerate clinical research, product development, and U.S. expansion. The company is led by CEO Sean LaNeve and CCO Shanth Thiyagalingam, with recent additions including board member Robert Kline (October 2025) and SVP of Clinical Research Lalit Venkatesan, PhD (January 2026). PainTEQ holds 16 granted U.S. patents covering implant design, surgical instruments, and fusion methods, with operations based at its Tampa headquarters and a Riverview, Florida distribution facility.

Name

PainTEQ

Legal name

PainTEQ

Website

https://painteq.com

Company type

Private

Founded year

2014

Operating status

Operating

Headcount range

101–250 employees

Short description

PainTEQ is a Tampa-based medical device company that develops and commercializes minimally invasive sacroiliac (SI) joint fusion systems, including the LinQ allograft implant and TRAQ bi-cortical fixation implant, sold to interventional pain specialists and spine surgeons across the United States.

Ownership category

akta.pro rank

Product category

Sacroiliac Joint Fusion Medical Devices

NAICS

Surgical Appliance and Supplies Manufacturing (339113), Surgical and Medical Instrument Manufacturing (339112)

SIC

Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Orthopedic Joint Reconstruction Implants (Hip/Knee/Shoulder/Elbow/Ankle) (HLAHAEAA)

Keywords

• Sacroiliac joint fusion
• SI joint stabilization
• Minimally invasive spine
• Medical implant devices
• Interventional pain management

Headquarters

HQ city

Tampa

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure

Revenue model

1. Medical Device Sales - Implants: PainTEQ generates revenue from the sale of its LinQ SI Joint Stabilization System implants to healthcare providers and surgical centers. The system includes the allograft implant, single-use surgical instruments, and supporting documentation.
2. Single-use Surgical Instruments: Disposable surgical kit components including mating inserters, cannulas, and decorticators used during the LinQ procedure

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels6 records

Core offering

PainTEQ develops, manufactures, and commercializes minimally invasive sacroiliac (SI) joint fusion medical implant systems, headlined by the LINQ SI Joint Stabilization System — a single bone allograft implant placed via a posterior, drill-less approach through a small incision in an outpatient setting. Its portfolio also includes the TRAQ bi-cortical fixation implant (U.S. commercial launch May 2026), complementary single-use surgical instrument kits, and the OfficeLinQ in-office procedure variant. These products are sold to pain management specialists, interventional spine physicians, and outpatient surgical centers.

Product overview

PainTEQ offers a portfolio of minimally invasive sacroiliac (SI) joint dysfunction solutions centered on two core implant systems: the LINQ SI Joint Stabilization System and the newer TRAQ implant. LINQ uses a single allograft implant placed via a posterior approach to stabilize the SI joint, while TRAQ provides bi-cortical fixation through the same surgical approach. Both products are complemented by single-use surgical instruments and the OfficeLinQ variant for in-office procedures. The company is expanding its evidence-based portfolio through landmark Randomized Controlled Trials, prospective studies (SECURE, TRAQTION), and biomechanics research.

Differentiator

Problem solved

Functional benefit

Brands

• LinQ: The LinQ SI Joint Stabilization System - a minimally invasive posterior SI joint fusion procedure using a single allograft implant.
• TRAQ

Products and services

• LINQ SI Joint Stabilization System Minimally invasive posterior sacroiliac joint fusion system that uses a single allograft implant (about the size of an almond) placed through a small incision to stabilize the dysfunctional SI joint and create an environment for long-term fusion; involves no metal implant and is performed as an outpatient/office-based procedure with faster recovery than traditional fusion. Sold to pain management specialists and interventional spine physicians.
• TRAQ Next-generation posterior sacroiliac joint implant designed to achieve bi-cortical fixation by engaging both the sacral and iliac cortices through a tissue-sparing 1-inch incision; the first posterior approach SI joint implant for bi-cortical fixation, expanding fixation options within PainTEQ's posterior surgical approach. Sold to interventional spine physicians and surgical centers.
• OfficeLinQ In-office version of the LINQ SI Joint Stabilization procedure that allows qualified physicians to perform the minimally invasive SI joint fusion in an office setting rather than a hospital or surgical center. Targeted at pain management practices seeking office-based procedure economics.
• Single-use Surgical Instruments Single-use surgical instrument kit for the LINQ procedure, including mating inserters, cannulas, and decorticators, sold to clinicians performing SI joint fusion as a complement to the LINQ allograft implant.

Quantifiable outcome

• 67.6% average pain relief across pain salvage study patients
• +8 more outcomes

Named customers5 records

Segments3 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

One partnership is on record.

• University of South Florida (USF)minorStrategic or Co-development Partner · 4 May 2026PainTEQ collaborated with USF College of Engineering and Morsani College of Medicine on corporate-sponsored capstone projects for biomedical engineering seniors. The program serves as a workforce pipeline for the Tampa-St. Petersburg medical technology hub.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Emerging players

• RTI Surgical: RTI Surgical supplies surgical allografts and biologics used across spine and orthopedic procedures, including allograft implants for SI joint fusion. It is a partial-overlap, enabling peer that competes with PainTEQ's allograft-based LinQ implant on the implant-material axis.
• Providence Medical Technology: Providence Medical Technology is a privately held spine medtech company focused on cervical and adjacent-segment pathology with emerging procedural offerings. It is an adjacent emerging player in minimally invasive spine that overlaps PainTEQ in serving interventional pain and spine practices.

Direct peers

• SI-Bone: SI-Bone is the market-leading pure-play in sacroiliac joint fusion with its iFuse Implant System, the most established lateral triangular-rod SI joint fusion device. It directly competes with PainTEQ's LinQ and TRAQ systems for the same pain management and spine surgeon customer base.
• Camber Spine: Camber Spine is a privately held spine-focused medical device company with minimally invasive SI joint fusion products (e.g., SICONUS). It is a closer-scale, niche competitor to PainTEQ targeting overlapping interventional pain and spine surgeon customers.
• CoreLink Surgical: CoreLink Surgical (now part of Spinal Elements following acquisition) developed the Sentry SI joint fusion system, a direct lateral-approach competitor to PainTEQ's posterior LinQ and TRAQ systems in the same SI joint fusion market.

Broad incumbents

• Stryker: Stryker operates a large spine and orthopedic surgery portfolio and has invested in SI joint fusion offerings via its spine division. It overlaps with PainTEQ in serving interventional pain specialists and spine surgeons, with much broader scale and resources.
• Orthofix Medical: Orthofix has spine and orthopedic implant franchises (including legacy SI joint offerings) and competes with PainTEQ for interventional pain management and spine surgeon relationships, though SI joint fusion is one component of a broader portfolio.
• Medtronic: Medtronic is a diversified medtech incumbent with deep spine surgery franchises and established hospital sales coverage that overlaps with PainTEQ's interventional pain and spine surgeon customers, though SI joint fusion is one of many spine subsegments it serves.
• Globus Medical: Globus Medical (following its merger with NuVasive) is a major spine medtech incumbent with an SI joint fusion portfolio (e.g., SIROS system) and broad hospital contracting leverage. It competes with PainTEQ across spine surgery channels while serving the same downstream SI joint patient population.
• Alphatec Holdings: Alphatec is a publicly traded spine-focused medtech company with a portfolio spanning cervical, thoracolumbar, and SI joint fusion. It overlaps with PainTEQ in serving interventional spine surgeons, though at meaningfully larger scale.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/channel/painteq
• Facebookfacebook.com/PainTEQ
• LinkedInlinkedin.com/company/painteq

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds2 records

Investors3 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about PainTEQ